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Karen H. Lu, M.D.

Professor of Gynecologic Oncology
H.E.B. Professorship in Cancer Research

108 Legends and Legacies

Karen tried on the cap and gown her
mother wore to receive her master’s
degree.

Both Karen and husband Charles
Lu, M.D., received medical degrees
from Yale University School of
Medicine in 1991.

Ned, 10, at left, and David, 14 can
count on parents Charles and Karen,
holding Kate, 2, to cheer for their
various sports teams.
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ow I ended up where I am today is much clearer when
examined in hindsight. Now, the choices I made that led me
to my life’s work as a gynecologic oncologist with a particular
interest in hereditary cancers make sense. These choices
were, in fact, not as random as they seemed at the time that
each decision had to be made. Values that I hold and that
were instilled in me — love of family, importance of the academic pursuit,
joy of teaching — all guided those decisions.
I was born and raised in Baltimore, Maryland. My parents came from
mainland China via Hong Kong to the United States to attend college and
graduate school in the 1950s. Both came from scholarly families in China,
and perhaps my commitment to academics comes from them. My paternal
grandfather was a professor of chemistry who was educated at Johns Hopkins
University. He was among a group of Chinese young men educated in the
United States with scholarship funds established by the United States after
the Boxer Rebellion. My maternal grandfather, a professor of economics,
was educated in France. He later served as the head of China’s legislature
before the Communist regime, but I knew him only as the kind grandfather
who played card games with me and gave me Juicy Fruit gum.
More recently, I have thought about the genetic link to my maternal
grandmother. She was one of the first female graduates of Beijing
University in the 1920s, where she majored in physics. Thereafter, she raised
four children, served as a political wife, moved her family around China
during the war in the early 1940s, and finally fled China for Hong Kong. I
remember my mother telling me that while the rest of the family stayed in
Hong Kong, my grandmother went to Malaysia by herself to teach college
physics in order to support the family. Did she think about career goals? Did
she worry about achieving the right balance of work and family life? Did
she experience difficulties in academics because she was a woman? What I
wouldn’t give to be able to have a conversation with her now!
In contrast to my parents’ and grandparents’ dramatic lives, my childhood
growing up in Baltimore was certainly less eventful. My immigrant parents
believed that the route to success for their children in this new country was
through education, so my brother and I went to traditional college prep
schools in Baltimore (boys’ school for him, girls’ school for me). I loved
attending an all-girls school because we were encouraged in every possible
way. There was never any question that my classmates and I could achieve
whatever we wanted to achieve, academically or otherwise. Contrary to the
stereotype of Chinese parents, my parents never pushed me or my older
brother academically, although I do think the ethic and value of scholarly
pursuit was always present for us. We were both encouraged equally. The
only time that my older brother felt any pressure from my dad was his gentle
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encouragement of my brother to go to Johns Hopkins, since both my dad
and grandfather had been students there. Since my brother chose to go there
for his undergraduate studies and for his Ph.D., by the time I was deciding
about colleges, the familial obligation had been fulfilled, and I headed north
to Harvard.
In college, I was a biochemistry major; I chose that major partly because
it led me to a smaller community within the university that was fairly
nurturing. We had one-on-one tutorials with faculty and were required to do
a project with a mentor that would lead to a thesis. I worked with David
Williams, an M.D.-Ph.D. doing a pediatric hematology-oncology fellowship
at Children’s Hospital. He was from the Midwest and was smart, hard
working and kind. Ultimately, what I valued from my experience with him
was that he was an incredibly decent human being with equal passions for
the research he was doing, for the pediatric cancer patients he was caring for
and for his young family. I learned about the dedication that research involves
(lots of weekends and nights with mice), and I learned about the value of
scientific pursuit in medicine. Looking back now, it seems that experience
must have influenced my decision to combine my own passions: for caring
for women with gynecologic cancers, for translational research, and for my
husband and three children.
One of my best experiences in college was meeting my future husband,
Charlie. We grew up together in college and were great friends. We dated
all through college, went our own ways for a few years, and then started
dating again when we both were at Yale Medical School. When it was time
to make decisions about matching for residencies, it seemed for us an easy
decision to get married and enter into the “couples match.” A “couples
match” allows two people to merge their prospects together in the lottery
that determines where medical students will do their residencies. It is a good
test in negotiation and compromise for couples, and we had a relatively
easy time deciding on our choices. By the time we got married at the end
of medical school, Charlie and I had known each other for almost 10 years.
I tell my sons that they need to really, really know someone before they get
married, and I use our 10-year standard for their reference. I may have to
revise my advice, but my point is this: having a long history with someone
makes facing the challenges of life easier.
We ended up in Boston for residency — Charlie in Internal Medicine
and me in Obstetrics and Gynecology. I loved residency. After all that
coursework, this was the time when you really learned to be a doctor, and
I loved all of it: delivering babies, surgery, clinic. My colleagues were fun,
and the ones who weren’t provided fodder for good humor. We worked like
dogs, but it was easy to feel a sense of instant gratification. I do remember
tough times of getting no sleep at night and then having to face a busy clinic
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the next day. My motto for nights on call was: you had to sleep or you had
to eat. If you couldn’t do one, you had to do the other.
During the end of my second year of residency, I had to start thinking
about whether to apply for a fellowship in one of the four subspecialties in
obstetrics/gynecology. I definitely had a preference for subspecializing, as
I didn’t think that being a general obstetrics/gynecology physician, which
usually meant private practice, fit me well. But what specialty? Urogynecology
had interesting vaginal surgery, but I had a hard time getting passionate
about urinary incontinence. The reproductive endocrinology and infertility
attendings did interesting laparoscopic surgery, but I wasn’t particularly
passionate about infertility or endocrinology. That left gynecologic oncology.
Not for the faint of heart, this field is unique in that it combines expertise
in complex surgeries with expertise in chemotherapy. For a resident, this is
one of the most exhausting yet most exhilarating and gratifying rotations.
At the time, it was not the obvious choice for me, but, looking back, I cannot
imagine a more suitable field. I am passionate about working with women
who have gynecologic cancers.
The fellowship was three years, and, since my husband had started his
medical oncology fellowship in Boston a year earlier, it made sense for me
to remain in Boston for my fellowship, too. And as much as I enjoyed my
residency, I enjoyed my fellowship more. The first year was a lab year, and I
worked in Sam Mok’s lab. Those in the field of ovarian cancer research know
him for his accomplishments in understanding the molecular pathogenesis
of disease. I had not thought seriously about lab work since college, but
Sam brought out the latent molecular biologist in me. During that year, I
understood the power of clinicians working with basic scientists. Sam had
expertise, techniques and tissues to study ovarian cancer. Sam gave all new
fellows in the lab a project that was already under way. After completing
this initial project, we could start thinking about our own ideas for studies.
This is what I loved. I could think of endless clinical scenarios in which
having a molecular biology answer would really be helpful. Sam taught me
the importance of having a tissue and serum bank. Because those resources
were in place, I was able to ask and answer clinical questions using molecular
biology and do it within a short period of time. Writing and submitting
abstracts, assembling posters (back then, there was a lot more cutting and
pasting), putting together PowerPoint presentations, and learning to write,
re-write, and (again) re-write a manuscript are skills that I learned during my
fellowship. You only have to do these things once or twice before the tasks
become easier and less daunting. I can unequivocally state that my style of
mentoring clinical gynecologic oncology fellows today derives directly from
the way in which I learned from Sam and others during my fellowship.
It was also during my fellowship that I developed my interest in hereditary
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cancer syndromes. BRCA1 and BRCA2 had recently been cloned, and there
were plenty of clinical questions that needed answering. I remember during
my clinical year taking care of a woman who was petrified that she would get
ovarian cancer. Multiple women in her family had died of this disease, and
she had recently found out that she carried a mutation in BRCA1. Although
she was only in her mid-30s, we were going to remove her ovaries, and she
was happy about it. Her surgery, done laparoscopically, was uneventful, and
she went home the same day. A week later, we heard from the pathologist
that both her ovaries and fallopian tubes showed microscopic pre-cancerous
changes. But, unlike her female relatives, whose ovarian cancer had been
diagnosed at stage 3 or 4 (when it is already widely disseminated, which
is typically when it is diagnosed), she had her ovaries removed just as the
cancerous process was beginning and, thus, was able to escape the fate of
her female relatives. This experience made the power of the discovery of
the BRCA1 and BRCA2 genes very real and vivid to me.
After spending 16 years in New England for college, medical school
and training, I was hoping that we would move home to Baltimore for our
first real jobs. Johns Hopkins and the National Cancer Institute (NCI) were
obvious choices, so very early on (the end of my second year in fellowship),
we approached our respective oncology departments there to ask about
opportunities. However, it was entirely obvious, from a few phone calls and
one interview, that neither was going to be a good fit for us.
Soon afterward, right before the start of my third year of fellowship,
Charlie attended a meeting in Colorado and ran into a friend who had
recently started work as an attending at M. D. Anderson Cancer Center
in Houston. Was Charlie starting to look for a job? Would he like to have
dinner with Dr. Waun Ki Hong the next evening? I remember the phone
conversation with my husband after he had met with Dr. Hong — great job,
great opportunity, great institution. Charlie flew down to Houston very soon
afterward for an interview, and I began to pay attention when he came home
and asked me if we could fax my resume to M. D. Anderson to see if there
was a job opening in gynecologic oncology. From there, things progressed
fairly quickly.
When Charlie went for his second interview, I went along. Although there
was no formal job opening for me, at that time the department and program
were expanding their translational research program in ovarian cancer. I
had already secured funding from the American Gynecologic and Obstetric
Society to do three years of translational research training. The enthusiasm
of Charlie’s three friends from Harvard was consistent and overwhelming:
for junior faculty wanting academic opportunities, M. D. Anderson was the
place to be. My lesson from this experience was this — start early to look for
jobs in places that you really think you want to go. If it doesn’t work, keep
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an open mind. It is likely that the best opportunity may surprise you.
I remember one of my mentors in the fellowship program saying that
you need to leave the institution where you trained so that you can grow
up. If you stay, your attendings will see you as their trainee, and, worse, you
will always feel like a trainee. I don’t know whether that is always the case,
but I do think it is good advice. It was healthy for me to leave Boston and
my comfort zone. I learned that I could meet a new set of colleagues, find
collaborators and mentors, figure out the way to a new operating room, and
establish myself.
Two very fortunate events that occurred early in my career have defined
the direction of my research and clinical interests. First, I came from my
fellowship with an interest in hereditary cancers. A significant portion of
my research as a fellow was devoted to ovarian cancer and BRCA1 and
BRCA2. When I came to M. D. Anderson, I wanted to continue that
interest but found out that there were fewer than 10 families with known
mutations — not enough raw material to do any substantive research. I
remember a chance encounter with Dr. Patrick Lynch, who led the registry
for Hereditary Non-polyposis Colorectal Cancer (HNPCC), now referred to
as Lynch syndrome. He said, “You know, we can never get any gynecologists
to study Lynch syndrome.” What lay in front of me was a rich registry and
expertise in a hereditary cancer syndrome in which women had an equal
and significant risk of developing endometrial and colon cancer as well as a
smaller but significant risk of ovarian cancer. I consider myself fortunate to
have fallen into such an opportunity.
The second fortuitous event occurred when my colleague Dr. Russell
Broaddus and I found out about a Request for Applications (RFA) from the
NCI to conduct an endometrial cancer chemoprevention study in women
with HNPCC. There had been very little studied on endometrial cancer
and Lynch syndrome in general, but the goal was to examine two agents
known to be effective in preventing endometrial cancer in the general
population: oral contraceptives and progesterone. To really get a study
like this done, two components would be necessary: 1) a registry of Lynch
syndrome families from which to draw eligible women, and 2) knowledge
of molecular biomarkers relevant to endometrial cancer that could be
used as surrogate endpoints. I think we believed that this was something
we had to do — where else was there such an established Lynch syndrome
registry and investigators interested in endometrial cancer prevention? In
addition, Russell knew a group at the UT Medical School that was studying
the molecular effects of estrogen on post-menopausal endometrium in the
context of hormone replacement therapy. Wouldn’t it make sense to look
at some of these same genes in endometrial cancer, which is believed to
result from too much estrogen in the endometrium? There was a fantastic
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opportunity to examine some of these novel genes as biomarkers. All the
necessary pieces were in place to apply for this grant, but there was one
catch. Neither of us had applied for this type of grant before, and the
deadline was only four weeks away. I call this our “soup to nuts” grant
submission. Russell and I had no expertise in putting together a budget or
in assembling a consortium of other institutions, which required even more
paperwork and more complicated budgeting. What we did have was youthful
enthusiasm and help from Dr. Lynch’s team, which had recently completed
a colon cancer chemoprevention study. We ended up getting the grant and
gaining a lot of confidence along the way. This year, five years later, we
completed accrual to this study. It took sheer force of will and a number of
very dedicated individuals to complete this trial, and ours is one of the few,
if not the only, gynecologic chemoprevention study for a hereditary cancer
syndrome that has actually completed accrual.
The same youthful enthusiasm that went into this first grant re-surfaced
when we began to consider submitting a uterine SPORE grant. I remember
Russell, Mai Dinh (our project coordinator) and I meeting with one of
our most respected mentors, Dr. George Stancel, who is dean of our UT
Graduate School for Biomedical Sciences. We had lunch with him and
proudly pronounced that we wanted to put a uterine SPORE grant together.
He gave us really sound advice: don’t do it. I give full credit to Russell and Dr.
Tom Burke for saying, “Let’s just try it anyway.” The deadline for submission
only gave us eight weeks to focus on preparing the grant, but, frankly, after
that chemoprevention grant went in, nothing seemed impossible. Because
of Congressional budget delays, we didn’t find out until some 18 months
after submission that the grant would be funded. By then, we just wanted
the money and to get started with the research. My continued love for the
research process has grown with the growth of the uterine cancer program,
both at our institution and nationwide. Our success has been partly due to
bringing in expertise from very different disciplines to focus on a cancer
that has been really understudied. The other key to our success has been to
encourage and draw in enthusiastic young scientists.
Looking back, I am surprised that I never considered the work-life
balance more carefully as I made my career decisions. I chose what most
would consider a time-intensive specialty because I liked it. Having children
was a given, and we planned as best we could. In my third year of residency,
I had a non-clinical six-week rotation, which I used for my first maternity
leave. Our second child was supposed to come during my non-clinical year
of fellowship, but perfect planning doesn’t always happen. Because I was a
busy clinical fellow and because I wanted to honor a promise to my senior
fellow that he could attend an important conference, I went back to work two
weeks after my second son was born. I approached each of my maternity
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leaves by taking extra call while pregnant, trading favors, and fulfilling my
job when I returned from leave. It is a delicate balance to have children
during medical training or even as an attending. I respected my colleagues
and didn’t want to ever feel that I wasn’t pulling my weight.
As for that last child, I had been on staff for six years, had been promoted
to associate professor, and at 41 was considered by the standards of my field
to be of “advanced maternal age.” We had finally cleared our house of all
the baby paraphernalia, since our boys were 12 and 8. I tell people that we
needed a shot of excitement into our well-balanced life. Our daughter has
provided that, and, after so many years without an infant, she reminded me
how difficult it is for working women to have babies. For us, what has always
worked was having lots of help, including a live-in nanny and my parents,
who take turns coming to Houston. Since my father is retired, he spends
weeks at a time with us here. He drives the morning carpool for the boys
and in the afternoon takes them to tennis, baseball or piano lessons. At their
games and tournaments, he is their biggest fan. My mother still teaches, and
she comes to visit and help out when she can. I know I could not be where
I am today without their help. Besides my husband and parents, there are
other key individuals who help make it possible for me to do the work that
I do. All working women need to understand the value of their assistants; I
know I would be nowhere without mine, Jeannette Upshaw.
I grew up with parents and teachers who assumed I would choose a
life’s work and pursue it passionately. Balancing the commitments of work
and family is difficult. Thus, choosing what you do in life becomes that much
more important. I believe that if you have a true passion for the things you
choose to pursue, whether personal or professional, the rewards will be well
worth the effort. So far, it’s been that way for me.

